The Cooper Companies, Inc. (NASDAQ:COO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Key Points

• The Cooper Companies, Inc. has received a consensus recommendation of "Moderate Buy" from fourteen brokerages, with an average 12-month price target of $84.75.
• Insider transactions revealed significant stock purchases, including CEO Albert G. White III buying 10,000 shares at an average cost of $68.39 each, indicating confidence in the company's future.
• The company recently announced a $2.00 billion stock repurchase program, allowing repurchase of up to 15.4% of its shares, often seen as a sign that the board believes the shares are undervalued.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, nine have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $84.75.

A number of brokerages have commented on COO. Loop Capital set a $100.00 price target on shares of Cooper Companies in a research note on Tuesday, June 17th. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the stock an "equal weight" rating in a research note on Thursday, August 28th. Mizuho cut their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Finally, Needham & Company LLC restated a "buy" rating and set a $94.00 price target on shares of Cooper Companies in a research note on Thursday, August 28th.

Insiders Place Their Bets

In other Cooper Companies news, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction dated Friday, September 5th. The shares were acquired at an average cost of $68.39 per share, with a total value of $683,900.00. Following the acquisition, the chief executive officer directly owned 226,151 shares of the company's stock, valued at $15,466,466.89. The trade was a 4.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel G. Mcbride bought 3,000 shares of Cooper Companies stock in a transaction dated Tuesday, September 2nd. The stock was acquired at an average cost of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the acquisition, the chief operating officer directly owned 63,120 shares in the company, valued at $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 17,975 shares of company stock worth $1,216,346 over the last ninety days. 1.98% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of COO. Mirae Asset Global Investments Co. Ltd. raised its position in Cooper Companies by 15.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock worth $2,194,000 after purchasing an additional 3,440 shares during the last quarter. DAVENPORT & Co LLC raised its position in Cooper Companies by 13.4% in the 1st quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after purchasing an additional 513 shares during the last quarter. Cerity Partners LLC raised its position in Cooper Companies by 6.6% in the 1st quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock worth $1,443,000 after purchasing an additional 1,054 shares during the last quarter. State of Alaska Department of Revenue raised its position in Cooper Companies by 3.0% in the 1st quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock worth $1,972,000 after purchasing an additional 680 shares during the last quarter. Finally, United Services Automobile Association bought a new position in Cooper Companies in the 1st quarter worth approximately $414,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 2.0%

COO stock opened at $68.37 on Friday. The company has a market cap of $13.59 billion, a PE ratio of 33.68, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $109.37. The business's 50-day simple moving average is $69.43 and its 200 day simple moving average is $73.73.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, research analysts anticipate that Cooper Companies will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has approved a stock repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.